Lifevantage ROE 2012-2026 | LFVN
Current and historical return on equity (ROE) values for Lifevantage (LFVN) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Lifevantage ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2026-06-30 | $0.00B | $0.03B | 12.03% |
| 2026-03-31 | $0.01B | $0.03B | 14.93% |
| 2025-12-31 | $0.01B | $0.03B | 20.74% |
| 2025-09-30 | $0.01B | $0.03B | 30.30% |
| 2025-06-30 | $0.01B | $0.03B | 31.50% |
| 2025-03-31 | $0.01B | $0.03B | 30.51% |
| 2024-12-31 | $0.01B | $0.03B | 28.83% |
| 2024-09-30 | $0.00B | $0.03B | 14.81% |
| 2024-06-30 | $0.00B | $0.03B | 11.01% |
| 2024-03-31 | $0.00B | $0.03B | 13.56% |
| 2023-12-31 | $0.00B | $0.03B | 9.68% |
| 2023-09-30 | $0.00B | $0.03B | 9.30% |
| 2023-06-30 | $0.00B | $0.03B | 9.09% |
| 2023-03-31 | $0.00B | $0.03B | 0.00% |
| 2022-12-31 | $0.00B | $0.03B | 0.00% |
| 2022-09-30 | $0.00B | $0.03B | 3.01% |
| 2022-06-30 | $0.00B | $0.04B | 8.70% |
| 2022-03-31 | $0.01B | $0.04B | 25.17% |
| 2021-12-31 | $0.01B | $0.04B | 27.59% |
| 2021-09-30 | $0.01B | $0.04B | 38.36% |
| 2021-06-30 | $0.01B | $0.04B | 36.36% |
| 2021-03-31 | $0.01B | $0.04B | 34.53% |
| 2020-12-31 | $0.01B | $0.03B | 36.36% |
| 2020-09-30 | $0.01B | $0.03B | 38.40% |
| 2020-06-30 | $0.01B | $0.03B | 39.67% |
| 2020-03-31 | $0.01B | $0.03B | 41.74% |
| 2019-12-31 | $0.01B | $0.03B | 43.24% |
| 2019-09-30 | $0.01B | $0.03B | 34.95% |
| 2019-06-30 | $0.01B | $0.02B | 32.99% |
| 2019-03-31 | $0.01B | $0.02B | 30.43% |
| 2018-12-31 | $0.01B | $0.02B | 32.56% |
| 2018-09-30 | $0.01B | $0.02B | 29.27% |
| 2018-06-30 | $0.01B | $0.02B | 32.43% |
| 2018-03-31 | $0.00B | $0.02B | 17.91% |
| 2017-12-31 | $0.00B | $0.02B | 6.45% |
| 2017-09-30 | $0.00B | $0.02B | 6.67% |
| 2017-06-30 | $0.00B | $0.02B | 6.90% |
| 2017-03-31 | $0.00B | $0.01B | 22.22% |
| 2016-12-31 | $0.00B | $0.01B | 32.65% |
| 2016-09-30 | $0.01B | $0.01B | 58.54% |
| 2016-06-30 | $0.01B | $0.01B | 75.00% |
| 2016-03-31 | $0.00B | $0.01B | 66.67% |
| 2015-12-31 | $0.00B | $0.01B | 88.89% |
| 2015-09-30 | $0.00B | $0.00B | 75.00% |
| 2015-06-30 | $0.01B | $0.01B | 155.56% |
| 2015-03-31 | $0.01B | $0.01B | 189.47% |
| 2014-12-31 | $0.01B | $0.01B | 210.53% |
| 2014-09-30 | $0.01B | $0.00B | 369.23% |
| 2014-06-30 | $0.01B | $0.01B | 97.56% |
| 2014-03-31 | $0.01B | $0.02B | 45.07% |
| 2013-12-31 | $0.01B | $0.03B | 34.95% |
| 2013-09-30 | $0.01B | $0.04B | 17.27% |
| 2013-06-30 | $0.01B | $0.04B | 20.29% |
| 2013-03-31 | $0.01B | $0.03B | 36.36% |
| 2012-12-31 | $0.00B | $0.03B | 13.33% |
| 2012-09-30 | $0.01B | $0.02B | 55.32% |
| 2012-06-30 | $0.01B | $0.01B | 118.18% |
| 2012-03-31 | $-0.04B | $0.00B | 3120.00% |
| 2011-12-31 | $-0.04B | $-0.01B | 429.27% |
| 2011-09-30 | $-0.05B | $-0.01B | 349.09% |
| 2011-06-30 | $-0.05B | $-0.01B | 408.00% |
| 2011-03-31 | $-0.01B | $-0.01B | 80.00% |
| 2010-12-31 | $-0.01B | $-0.01B | 62.22% |
| 2010-09-30 | $-0.01B | $-0.01B | 115.56% |
| 2010-06-30 | $-0.01B | $-0.01B | 133.33% |
| 2010-03-31 | $-0.01B | $-0.01B | 173.33% |
| 2009-12-31 | $-0.01B | $-0.01B | 152.38% |
| 2009-09-30 | $-0.01B | $0.00B | 246.15% |
| 2009-06-30 | $-0.01B | $0.00B | 720.00% |
| 2009-03-31 | $-0.01B | $0.00B | -400.00% |
| 2008-12-31 | $0.00B | $0.00B | -100.00% |
| 2008-09-30 | $0.00B | $0.00B | -61.54% |
| 2008-06-30 | $0.00B | $0.00B | -57.14% |
| 2008-03-31 | $0.00B | $0.00B | -57.14% |
| 2007-12-31 | $0.00B | $0.00B | -57.14% |
| 2007-09-30 | $0.00B | $0.00B | -123.08% |
| 2007-06-30 | $-0.01B | $0.00B | -142.86% |
| 2007-03-31 | $-0.01B | $0.01B | -126.32% |
| 2006-12-31 | $-0.01B | $0.01B | -92.31% |
| 2006-09-30 | $-0.01B | $0.01B | -58.82% |
| 2006-06-30 | $0.00B | $0.01B | -40.00% |
| 2006-03-31 | $0.00B | $0.01B | 37.21% |
| 2005-12-31 | $-0.01B | $0.01B | -70.59% |
| 2005-09-30 | $-0.01B | $0.01B | -104.35% |
| 2005-06-30 | $-0.01B | $0.00B | -200.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.077B | $0.183B |
| Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $104.880B | 22.04 |
| Cardinal Health (CAH) | United States | $54.109B | 20.66 |
| Becton Dickinson (BDX) | United States | $51.228B | 14.30 |
| West Pharmaceutical Services (WST) | United States | $25.687B | 42.94 |
| Straumann Holding AG (SAUHY) | Switzerland | $18.592B | 0.00 |
| Align Technology (ALGN) | United States | $10.528B | 16.28 |
| Cooper (COO) | United States | $10.130B | 11.56 |
| Henry Schein (HSIC) | United States | $9.754B | 16.48 |
| Merit Medical Systems (MMSI) | United States | $5.146B | 23.48 |
| DENTSPLY SIRONA (XRAY) | United States | $1.960B | 6.87 |
| CONMED (CNMD) | United States | $1.406B | 9.82 |
| STAAR Surgical (STAA) | United States | $1.125B | 35.07 |
| Pro-Dex (PDEX) | United States | $0.214B | 19.97 |